These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of autoantibodies in demyelinating disorders of the central nervous system]. Tanaka K; Tanaka M Nihon Rinsho; 2014 Nov; 72(11):2067-72. PubMed ID: 25518394 [TBL] [Abstract][Full Text] [Related]
8. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Saikali P; Cayrol R; Vincent T Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490 [TBL] [Abstract][Full Text] [Related]
9. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review]. Yoshida M Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307 [TBL] [Abstract][Full Text] [Related]
10. [Molecular pathology of multiple sclerosis and neuromyelitis optica]. Masaki K Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370 [TBL] [Abstract][Full Text] [Related]
11. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies]. Jordan B; Eger K; Kornhuber ME; Zierz S Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220 [TBL] [Abstract][Full Text] [Related]
12. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296 [TBL] [Abstract][Full Text] [Related]
13. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan. Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778 [TBL] [Abstract][Full Text] [Related]
14. [Search for the pathogenesis of multiple sclerosis from the bedside]. Kira J Rinsho Shinkeigaku; 2008 Nov; 48(11):931-3. PubMed ID: 19198121 [TBL] [Abstract][Full Text] [Related]
15. Antibodies as biological markers for pathophysiological processes in MS. Reindl M; Khalil M; Berger T J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337 [TBL] [Abstract][Full Text] [Related]
16. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009 [TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810 [TBL] [Abstract][Full Text] [Related]
18. Homogeneity of active demyelinating lesions in established multiple sclerosis. Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988 [TBL] [Abstract][Full Text] [Related]
20. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]